Here, the authors elucidate the biosynthetic pathway of ECH in Cistanche tubulosa and synthesize 23 PhGs in tobacco. Applying the CRISPR-Cas9 system to edit high GC content genomes has been ...
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.
Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...
Using sequencing techniques, the study identified and analyzed the main actions and regulatory mechanisms of PFOA to better understand its specific molecular targets and pathways. In order to evaluate ...
When all of the trade dust was settled, Portland ended up with Deandre Ayton, Toumani Camara, and Robert Williams III. They still have all three guys on the roster, at least for now. Williams III ...
As an efficient gene editing tool, the CRISPR/Cas9 system has been widely employed to investigate and regulate the biosynthetic pathways of active ingredients in medicinal plants. CRISPR technology ...
Safety John Johnson III headlined Snead's roster moves, being activated off of injured reserve. As a result, Johnson III fills Blake Corum's roster spot as the rookie running back was put on IR ...
北京东目仪器有限公司位于全国的心脏首都-----北京,是一家主要从事仪器仪表开发、研制、*于一体的多元的高科技企业,拥有行业内*秀的技术与销售团队,熟悉国内外上千家仪研所及制造厂商的上万个品种的仪器及仪表。 我们经营的国内外产品绝大部分是 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing. We’ve issued final ...